Compare Extra Space Storage, Inc. (EXR) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs Regeneron Pharmaceuticals Inc — how do they compare? Extra Space Storage, Inc. trades at $133.26 (market cap $27.82B), while Regeneron Pharmaceuticals Inc trades at $739.58 (market cap $76.40B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 2.7× Extra Space Storage, Inc.'s market cap, and Extra Space Storage, Inc. pays the higher dividend (4.92%). Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 108 Days and Regeneron Pharmaceuticals Inc for 107 Days on average.
| EXR | REGN | |
|---|---|---|
Market Cap | $27.82B | $76.40B |
Volume | 1,465,973 | 626,381 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $852.03 |
52-Week Low | $126.67 | $557.73 |
Typical Hold Time | 108 Days | 107 Days |
Enterprise Value | $41.54B | $71.12B |
Dividend Yield | 4.92% | 0.51% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Extra Space Storage (EXR) trades at $133.12, down 0.58% on the day, amid a bearish technical signal. The company shows strong fundamentals with revenue of $3.38B in 2025 and a net income margin of 27.79%. Recent earnings have consistently beaten expectations, and a leadership transition is set for 2027. Analyst consensus is split evenly between Buy and Hold, with a price target of $158.33, suggesting potential upside.
The outlook is balanced: solid operational performance and dividend payments support the stock, but high valuation ratios and a bearish technical trend present near-term risks. Investors should weigh the company's steady growth against market sentiment and debt levels.
Regeneron Pharmaceuticals (REGN) trades at $739.57, up 0.12% on the day, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, and the company maintains robust profitability with a net income margin of 27.86%. A major $8 billion expansion of the immunology alliance with Sanofi, announced October 1, 2026, provides significant future revenue potential and strategic momentum.
The outlook is positive, supported by strong earnings, a lucrative partnership, and a consensus analyst price target of $846. Key risks include competitive pressures in key drug markets and reliance on successful clinical trial outcomes. The stock presents a compelling opportunity for growth investors, though volatility may persist near-term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
